Envy Medical launches world-class patented Advanced Dermalinfusion Technology

NewsGuard 100/100 Score

Envy Medical, Inc. launches SilkPeel3, the next generation of its world class patented Advanced Dermalinfusion Technology. Unveiled originally in 2005, SilkPeel is celebrating its 10th birthday in style with fresh features, enhanced functionality and a sleek new design.

In the past decade, SilkPeel has expanded to over 40 countries, with 3,000 systems in use worldwide. It has also developed a solid celebrity fan base thanks to the gentle, non-irritating technology and immediate "wow" factor. A longtime favorite of A-listers, SilkPeel is one of the most coveted treatments at destination spas like The Spa at Four Seasons Hotel Los Angeles at Beverly Hills with a following that includes Katie Couric and the Olsen twins.

As the first and only true Dermalinfusion system, SilkPeel combines non-invasive exfoliation with the delivery of condition-specific solutions under pressure. These solutions are targeted toward the individual skin needs of the client and can address acne, dryness, dull skin, aging, sun damage and pigmentation.

"Our R&D team has been listening to doctors and skincare professionals as they have expanded their use of Dermalinfusion, treating new areas of the body and skin textural issues," says Curtis Cluff, CEO of Envy Medical, Inc. "Based on their feedback, we upgraded the SilkPeel design, improved the features and enhanced the functions to exceed the expanding needs of our clients."

SilkPeel3 is an exponential advancement in ease-of-use, functionality, and efficacy. It is sleeker, more compact and has an innovative "IndiviDUAL Infusion" dual-port design that loads two serum solutions at once, allowing for more tailored treatments that address multiple skin concerns. SilkPeel3 can now treat blemishes, dry skin, dark spots and a host of other common skin concerns in one quick and simple session.

"The dual-port design will make combination treatments catering directly to individual needs a reality," says Felipe Jimenez, Ph.D., Envy's Chief Scientific Officer. "For a patient with combination skin, we can use an infusion of ClarityMD across the oily T-zone and then switch to a hydrating solution for drier areas, ensuring optimal results for all skin types." Continues Dr. Jimenez, "For our providers, SilkPeel3 gives a wider variety of treatment offerings and protocols."

Additional improvements include the ergonomically improved "Plexus" hand piece with the option of new disposable medical-grade stainless steel treatment tips that make the treatment more comfortable and effective by eliminating incomplete passes and delivering more powerful and precise pneumatic vacuum results. Clients will be able to see impurities being removed from their skin in real time, so they can actually visualize their skin getting cleaner.

The new SilkPeel3 offers an even wider treatment range, expanding the system's efficacy to multiple body applications as well. When treating the body, SilkPeel3's higher vacuum power settings improve the appearance of cellulite and restore skin elasticity, while the lower settings help address stretch marks, truncal acne and rough patches.

Source:

Envy Medical, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy